Question A:
Expanding health insurance to more people through the ACA’s public subsidies and Medicaid expansion will reduce total healthcare spending in the economy.
Responses
© 2025. Kent A. Clark Center for Global Markets.
5%
2%
14%
38%
33%
7%
0%
Responses weighted by each expert's confidence
© 2025. Kent A. Clark Center for Global Markets.
22%
41%
30%
7%
0%
Question B:
Expanding health insurance to more people through the ACA’s public subsidies and Medicaid expansion will generate gains in the health and well-being of the newly insured that exceed the costs.
Responses
© 2025. Kent A. Clark Center for Global Markets.
5%
0%
0%
5%
21%
55%
14%
Responses weighted by each expert's confidence
© 2025. Kent A. Clark Center for Global Markets.
0%
3%
19%
58%
20%
Question A Participant Responses
Participant |
University |
Vote |
Confidence |
Bio/Vote History |
---|---|---|---|---|
![]() Daron Acemoglu |
MIT | Bio/Vote History | ||
|
||||
![]() Alberto Alesina |
Harvard | Bio/Vote History | ||
|
||||
![]() Joseph Altonji |
Yale | Bio/Vote History | ||
|
||||
![]() Alan Auerbach |
Berkeley | Bio/Vote History | ||
|
||||
![]() David Autor |
MIT | Bio/Vote History | ||
First result from Oregon study: People with health insurance use more healthcare
|
||||
![]() Katherine Baicker |
University of Chicago | Bio/Vote History | ||
|
||||
![]() Abhijit Banerjee |
MIT | Bio/Vote History | ||
|
||||
![]() Marianne Bertrand |
Chicago | Bio/Vote History | ||
|
||||
![]() Markus Brunnermeier |
Princeton | Bio/Vote History | ||
|
||||
![]() Raj Chetty |
Harvard | Bio/Vote History | ||
|
||||
![]() Judith Chevalier |
Yale | Bio/Vote History | ||
It is unlikely to reduce healthcare spending, but I am not aware of a full assessment.
-see background information here |
||||
![]() David Cutler |
Harvard | Bio/Vote History | ||
The timing is really important here. Long term can be very different from short term; costs more likely to fall in the long term.
|
||||
![]() Angus Deaton |
Princeton | Bio/Vote History | ||
|
||||
![]() Darrell Duffie |
Stanford | Bio/Vote History | ||
It's hard to believe that spending per person receiving services will go down enough to offset the number of people getting health care.
|
||||
![]() Aaron Edlin |
Berkeley | Bio/Vote History | ||
More insurance could lead to more usage and more spending. The countervailing hope is cost containment or prevention of expensive treatment.
|
||||
![]() Barry Eichengreen |
Berkeley | Bio/Vote History | ||
Many countervailing factors, though I am weakly inclined toward the agree side of uncertain.
|
||||
![]() Liran Einav |
Stanford | Bio/Vote History | ||
|
||||
![]() Ray Fair |
Yale | Bio/Vote History | ||
|
||||
![]() Amy Finkelstein |
MIT | Bio/Vote History | ||
Basic economic theory (demand curves slope down) + tons empirical evidence - RAND HIE + Oregon HIE + many quasi-experimental studies
|
||||
![]() Pinelopi Goldberg |
Yale | Bio/Vote History | ||
|
||||
![]() Austan Goolsbee |
Chicago | Bio/Vote History | ||
|
||||
![]() Michael Greenstone |
University of Chicago | Bio/Vote History | ||
|
||||
Robert Hall |
Stanford | Bio/Vote History | ||
The ACA caved to demands for excessively broad coverage.
|
||||
![]() Oliver Hart |
Harvard | Bio/Vote History | ||
It could fall as people get more preventative care; or rise as people use doctors more. Some evidence suggests the latter but it's early.
|
||||
![]() Bengt Holmström |
MIT | Bio/Vote History | ||
|
||||
![]() Caroline Hoxby |
Stanford | Bio/Vote History | ||
|
||||
![]() Hilary Hoynes |
Berkeley | Bio/Vote History | ||
|
||||
![]() Kenneth Judd |
Stanford | Bio/Vote History | ||
|
||||
![]() Steven Kaplan |
Chicago Booth | Bio/Vote History | ||
When you increase availability, you get more demand. In our institutional environment, very hard to see how costs do not go up.
|
||||
![]() Anil Kashyap |
Chicago Booth | Bio/Vote History | ||
|
||||
![]() Pete Klenow |
Stanford | Bio/Vote History | ||
|
||||
![]() Jonathan Levin |
Stanford | Did Not Answer | Bio/Vote History | |
|
||||
![]() Eric Maskin |
Harvard | Bio/Vote History | ||
Certain kinds of acute-care spending may fall due to better preventative care. But an overall fall in spending seems unlikely
|
||||
![]() William Nordhaus |
Yale | Bio/Vote History | ||
|
||||
![]() Emmanuel Saez |
Berkeley | Bio/Vote History | ||
|
||||
![]() Larry Samuelson |
Yale | Bio/Vote History | ||
Health care insurance should provide care more efficiently than the current lack of insurance coupled with reliance on emergency services.
|
||||
![]() José Scheinkman |
Columbia University | Bio/Vote History | ||
|
||||
![]() Richard Schmalensee |
MIT | Bio/Vote History | ||
A big switch from reliance on emergency rooms to prevention could do this, but this does not seem likely.
|
||||
![]() Carl Shapiro |
Berkeley | Bio/Vote History | ||
|
||||
![]() Robert Shimer |
University of Chicago | Did Not Answer | Bio/Vote History | |
|
||||
![]() Richard Thaler |
Chicago Booth | Bio/Vote History | ||
Obviously could go either way.
|
||||
![]() Christopher Udry |
Northwestern | Bio/Vote History | ||
Demand curves usually slope down. Evidence is that this is true for health care. Cost savings measures will mitigate but not outweigh this.
|
Question B Participant Responses
Participant |
University |
Vote |
Confidence |
Bio/Vote History |
---|---|---|---|---|
![]() Daron Acemoglu |
MIT | Bio/Vote History | ||
A lot of uncertainty, and ACA has a lot of problems (esp. to rein in costs and tackle distortions). Probably still benefits outweigh costs.
|
||||
![]() Alberto Alesina |
Harvard | Bio/Vote History | ||
|
||||
![]() Joseph Altonji |
Yale | Bio/Vote History | ||
|
||||
![]() Alan Auerbach |
Berkeley | Bio/Vote History | ||
|
||||
![]() David Autor |
MIT | Bio/Vote History | ||
That's just a prior. No evidence yet
|
||||
![]() Katherine Baicker |
University of Chicago | Bio/Vote History | ||
|
||||
![]() Abhijit Banerjee |
MIT | Bio/Vote History | ||
|
||||
![]() Marianne Bertrand |
Chicago | Bio/Vote History | ||
|
||||
![]() Markus Brunnermeier |
Princeton | Bio/Vote History | ||
|
||||
![]() Raj Chetty |
Harvard | Bio/Vote History | ||
|
||||
![]() Judith Chevalier |
Yale | Bio/Vote History | ||
Likely yes, though there are substantial uncertainties.
|
||||
![]() David Cutler |
Harvard | Bio/Vote History | ||
|
||||
![]() Angus Deaton |
Princeton | Bio/Vote History | ||
|
||||
![]() Darrell Duffie |
Stanford | Bio/Vote History | ||
The resulting gains include better health for newly covered, and fewer preventable high-cost diseases to treat. The total should be enough.
|
||||
![]() Aaron Edlin |
Berkeley | Bio/Vote History | ||
|
||||
![]() Barry Eichengreen |
Berkeley | Bio/Vote History | ||
|
||||
![]() Liran Einav |
Stanford | Bio/Vote History | ||
|
||||
![]() Ray Fair |
Yale | Bio/Vote History | ||
|
||||
![]() Amy Finkelstein |
MIT | Bio/Vote History | ||
|
||||
![]() Pinelopi Goldberg |
Yale | Bio/Vote History | ||
|
||||
![]() Austan Goolsbee |
Chicago | Bio/Vote History | ||
|
||||
![]() Michael Greenstone |
University of Chicago | Bio/Vote History | ||
i think yes but ultimately involves thorny issues of valuing improvements in health and reductions in consumption risk
|
||||
Robert Hall |
Stanford | Bio/Vote History | ||
The expansion of coverage was mainly intended to bring in healthy people whose payments would exceed their medical costs.
|
||||
![]() Oliver Hart |
Harvard | Bio/Vote History | ||
ACA allows ill people to see doctors and provides peace of mind. Both would be negotiated behind the veil of ignorance. Net benefit>0.
|
||||
![]() Bengt Holmström |
MIT | Bio/Vote History | ||
|
||||
![]() Caroline Hoxby |
Stanford | Bio/Vote History | ||
|
||||
![]() Hilary Hoynes |
Berkeley | Bio/Vote History | ||
|
||||
![]() Kenneth Judd |
Stanford | Bio/Vote History | ||
|
||||
![]() Steven Kaplan |
Chicago Booth | Bio/Vote History | ||
The experiments in Oregon suggest the benefits are modest and the costs higher. But, there is stiil much uncertainty.
|
||||
![]() Anil Kashyap |
Chicago Booth | Bio/Vote History | ||
|
||||
![]() Pete Klenow |
Stanford | Bio/Vote History | ||
|
||||
![]() Jonathan Levin |
Stanford | Did Not Answer | Bio/Vote History | |
|
||||
![]() Eric Maskin |
Harvard | Bio/Vote History | ||
|
||||
![]() William Nordhaus |
Yale | Bio/Vote History | ||
|
||||
![]() Emmanuel Saez |
Berkeley | Bio/Vote History | ||
|
||||
![]() Larry Samuelson |
Yale | Bio/Vote History | ||
Basic medical care, especially preventative care, brings gains that are large compared to the costs.
|
||||
![]() José Scheinkman |
Columbia University | Bio/Vote History | ||
|
||||
![]() Richard Schmalensee |
MIT | Bio/Vote History | ||
This is, of course, the rationale for the program, and it is not implausible.
|
||||
![]() Carl Shapiro |
Berkeley | Bio/Vote History | ||
|
||||
![]() Robert Shimer |
University of Chicago | Did Not Answer | Bio/Vote History | |
|
||||
![]() Richard Thaler |
Chicago Booth | Bio/Vote History | ||
|
||||
![]() Christopher Udry |
Northwestern | Bio/Vote History | ||
Very difficult question. Counting cost properly is hard enough; valuing the benefits even more challenging.
|